Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun;25(6):559-568.
doi: 10.1007/s11912-023-01359-8. Epub 2023 Mar 20.

Integrative Medicine for Ovarian Cancer

Eran Ben-Arye  1   2 , Ofer Lavie  3 , Wolfgang Heyl  4 , Lois Ramondetta  5 , Tara Berman  6 , Noah Samuels  7
Affiliations
Review

Integrative Medicine for Ovarian Cancer

Eran Ben-Arye et al. Curr Oncol Rep. 2023 Jun.

Abstract

Purpose of review: Integrative oncology (IO) services provide a wide range of complementary medicine therapies, many of which can augment the beneficial effects of conventional supportive and palliative care for patients with ovarian cancer. This study aims to assess the current state of integrative oncology research in ovarian cancer care.

Recent findings: We review the clinical research both supporting the effectiveness of leading IO modalities in ovarian cancer care as well as addressing potential safety-related concerns. There is growing amount of clinical research supporting the use of IO and implementation of integrative gynecological oncology models of care within the conventional supportive cancer care setting. Additional research is still needed in order to create clinical guidelines for IO interventions for the treatment of female patients with ovarian cancer. These guidelines need to address both effectiveness and safety-related issues, providing oncology healthcare professionals with indications for which these patients can be referred to the IO treatment program.

Keywords: Chemotherapy; Gynecologic oncology; Integrative oncology; Ovarian cancer.

PubMed Disclaimer

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660 . - DOI - PubMed
    1. Seidman JD, Ronnett BM, Shih IM, Cho KR, Kurman RJ. Epithelial tumors of the ovary. In: Kurman RJ, Hedrick Ellenson L, Ronnett BM (Eds). Blaustein’s Pathology of the Female Genital Tract, 7th Edition. Springer 2019
    1. Ferrell B, Cullinane CA, Ervine K, et al. Perspectives on the impact of ovarian cancer: women’s views of quality of life. Oncol Nurs Forum. 2005;32(6):1143–9. - DOI - PubMed
    1. Seibaek L, Hounsgaard L, Hvidt NC. Secular, spiritual, and religious existential concerns of women with ovarian cancer during final diagnostics and start of treatment. Evid Based Complement Alternat Med. 2013;2013:765419. https://doi.org/10.1155/2013/765419 . - DOI - PubMed - PMC
    1. Brown AJ, Sun CC, Urbauer DL, Bodurka DC, Thaker PH, Ramondetta LM. Feeling powerless: Locus of control as a potential target for supportive care interventions to increase quality of life and decrease anxiety in ovarian cancer patients. Gynecol Oncol. 2015;138(2):388–93. https://doi.org/10.1016/j.ygyno.2015.05.005 . - DOI - PubMed

LinkOut - more resources